非整倍体咨询的植入前基因检测 (PGT-A)
为接受体外受精 (IVF) 的患者提供非整倍体植入前基因检测 (PGT-A) 咨询
Purpose: To evaluate preimplantation genetic testing counseling interventions on patients undergoing in vitro fertilization treatment.
Preimplantation genetic testing for aneuploidy (PGT) allows patients undergoing in vitro fertilization (IVF) to screen embryos for genetic disorders. Preimplantation genetic testing for aneuploidy (PGT-A) is the testing most commonly ordered, and it screens for whole chromosome and large partial chromosome duplications or deletions. Currently, patient counseling varies based on the clinic, ranging from appointments to group seminars with a genetic counselor (GC), geneticist or reproductive endocrinology and infertility (REI) physicians for education regarding PGT. Patient knowledge regarding PGT has been varied with some studies indicating sufficient knowledge, while other studies have shown a potential lack of knowledge. One study indicated a third of patients had regret regarding their decision of whether or not to use PGT-A during IVF and another study indicated patients who choose to undergo PGT did so for reasons that were not evidence based. Additionally, educational materials have been illustrated to be inconsistent and with inappropriate literacy in regards to PGT counseling. One study has shown the potential of improvement with written intervention amongst providers and patients in regards to PGT related to a single genetic condition. The investigators hope to assess the efficacy of PGT-A educational and counseling interventions on patients undergoing IVF.
研究概览
详细说明
Procedures: Patients undergoing IVF for the first time will be randomized to one of three groups
- Provider counseling (current standard care) with pre-test
- Handout on PGT-A and provider counseling (current standard care + educational intervention) with pre-test
- Handout on PGT-A, provider counseling and brief genetic counselor counseling (current standard of care + educational and counseling interventions) with pre-test
All patients will receive provider counseling(current standard of care) on PGT-A during their new IVF clinic visit. All groups will take a pre-test on PGT-A prior to receiving provider counseling and (if in an intervention group) prior to receiving handout or handout with brief counseling on PGT-A from a genetic counselor. At the end of their clinic visit, all participants will complete a post-test on PGT-A.
Two weeks after their clinic visit, all participants will receive a 2nd post-test on PGT-A and the SURE questionnaire to assess retained knowledge about PGT-A and decisional conflict about their choice to use PGT-A in their treatment cycle.
As there is not a validated knowledge survey for PGT-A, investigators have developed their own for pre- and post-tests. In order to validate the survey prior to using it in this study, investigators plan to enroll the first 100 participants in a pilot study to validate the instrument. The number needed for validation will depend on how much pilot participants scores vary between pre and post test. Participants in the pilot portion of the study will be asked to complete a pre-test on PGT-A, read the informational handout about PGT-A, and then complete a post test on PGT-A prior to their IVF appointment. Statisticians will analyze the pilot data as received, and will inform investigators when a sufficient number has been reached for survey validation. Once validated, the pilot arm of the study will be closed and will begin enrolling participants in the randomized trial portion described above.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Iowa
-
Iowa City、Iowa、美国、52245
- University of Iowa
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients undergoing in vitro fertilization (IVF)
Exclusion Criteria:
- Patients who have previously undergone IVF would be excluded.
- Patients who have previously discussed PGT with a genetic counselor would be excluded.
- Patients who do not speak English will be excluded.
- Patients who are employees of the clinic would be excluded.
- Patients who have an indication for PGT-M or PGT-SR would be excluded.
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
无干预:Provider counseling with pre-test
Counseling regarding PGT-A only with a provider(current standard of care), pre-test provided. |
|
|
实验性的:Handout on PGT-A and provider counseling with pre-test
Counseling regarding PGT-A with a provider and review of a handout(educational intervention), pre-test provided. |
Educational handout on PGT-A |
|
实验性的:Handout on PGT-A, provider counseling and brief genetic counselor counseling with pre-test
Counseling regarding PGT-A only with a provider, review of a handout(educational intervention) and genetic counseling (counseling intervention), pre-test provided. |
Educational handout on PGT-A Handout on PGT-A and genetic counseling session with a genetic counselor on PGT-A |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
PGT-A Knowledge scores
大体时间:Prior to new IVF visit
|
Study team designed 7 item knowledge questionnaire. Lowest score being 0 and highest score being 7. |
Prior to new IVF visit
|
|
PGT-A Knowledge scores
大体时间:Immediately following new IVF visit
|
Study team designed 7 item knowledge questionnaire. Lowest score being 0 and highest score being 7. |
Immediately following new IVF visit
|
|
PGT-A Knowledge scores
大体时间:Two weeks post IVF visit.
|
Study team designed 7 item knowledge questionnaire. Lowest score being 0 and highest score being 7. |
Two weeks post IVF visit.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Decisional conflict as measured by the SURE questionnaire.
大体时间:Two weeks post IVF visit.
|
A validated questionnaire assessing patient decisional conflict on a scale of 0 to 4. Zero indicating no decisional conflict and 1 or greater indicating increasing levels of decisional conflict. |
Two weeks post IVF visit.
|
合作者和调查者
调查人员
- 研究主任:Prapti Singh, DO、University of Iowa
出版物和有用的链接
一般刊物
- Gebhart MB, Hines RS, Penman A, Holland AC. How do patient perceived determinants influence the decision-making process to accept or decline preimplantation genetic screening? Fertil Steril. 2016 Jan;105(1):188-93. doi: 10.1016/j.fertnstert.2015.09.022. Epub 2015 Oct 24.
- Lee I, Alur-Gupta S, Gallop R, Dokras A. Utilization of preimplantation genetic testing for monogenic disorders. Fertil Steril. 2020 Oct;114(4):854-860. doi: 10.1016/j.fertnstert.2020.05.045.
- Kaing A, Rosen MP, Quinn MM. Perceptions, motivations and decision regret surrounding preimplantation genetic testing for aneuploidy. Hum Reprod. 2020 Sep 1;35(9):2047-2057. doi: 10.1093/humrep/deaa154.
- Quinn MM, Juarez-Hernandez F, Dunn M, Okamura RJ, Cedars MI, Rosen MP. Decision-making surrounding the use of preimplantation genetic testing for aneuploidy reveals misunderstanding regarding its benefit. J Assist Reprod Genet. 2018 Dec;35(12):2155-2159. doi: 10.1007/s10815-018-1337-8. Epub 2018 Oct 18.
- McGowan ML, Burant CJ, Moran R, Farrell R. Patient education and informed consent for preimplantation genetic diagnosis: health literacy for genetics and assisted reproductive technology. Genet Med. 2009 Sep;11(9):640-5. doi: 10.1097/GIM.0b013e3181ac6b52.
- Early ML, Kumar P, Marcell AV, Lawson C, Christianson M, Pecker LH. Literacy assessment of preimplantation genetic patient education materials exceed national reading levels. J Assist Reprod Genet. 2020 Aug;37(8):1913-1922. doi: 10.1007/s10815-020-01837-z. Epub 2020 May 29.
- Early ML, Strodel RJ, Lake IV, Ruddy JA, Saba JA, Singh SM, Lanzkron S, Mack JW, Meier ER, Christianson MS, Pecker LH. Acceptable, hopeful, and useful: development and mixed-method evaluation of an educational tool about reproductive options for people with sickle cell disease or trait. J Assist Reprod Genet. 2022 Jan;39(1):183-193. doi: 10.1007/s10815-021-02358-z. Epub 2021 Nov 22.
- Singh P, Summers KM, Chanouha N, Thoeny R, Zorn A, Van Voorhis BJ, Sparks AE, Eapen A, Faro EZ, Pawlak SA, Duran EH. A randomized controlled trial of counseling and educational methods on preimplantation genetic testing for aneuploidy for patients pursuing in vitro fertilization. Fertil Steril. 2025 Nov 15;124(5 Pt 2):964-973. doi: 10.1016/j.fertnstert.2025.06.010. Epub 2025 Jun 14.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 202208644
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.